Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
ALNY - COMMON STOCK
Common Stock ALNY - Alnylam Pharmaceuticals, Inc.
1.29 M
LAST VALUE
2.11%
2 YEAR CAGR
2.88%
5 YEAR CAGR
5.29%
10 YEAR CAGR